Glucose and Fat Metabolism in Narcolepsy and the Effect of Sodium Oxybate: A Hyperinsulinemic-Euglycemic Clamp Study
Tóm tắt
Từ khóa
Tài liệu tham khảo
Overeem, 2001, Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives, J Clin Neurophysiol, 18, 78, 10.1097/00004691-200103000-00002
Spiegel, 2005, Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes, J Appl Physiol, 99, 2008, 10.1152/japplphysiol.00660.2005
Thannickal, 2000, Reduced number of hypocretin neurons in human narcolepsy, Neuron, 27, 469, 10.1016/S0896-6273(00)00058-1
Peyron, 2000, A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains, Nat Med, 6, 991, 10.1038/79690
Willie, 2001, To eat or to sleep? Orexin in the regulation of feeding and wakefulness, Annu Rev Neurosci, 24, 429, 10.1146/annurev.neuro.24.1.429
Taylor, 2003, The other side of the orexins: endocrine and metabolic actions, Am J Physiol Endocrinol Metab, 284, E13, 10.1152/ajpendo.00359.2002
Girault, 2012, Orexins, feeding, and energy balance, Prog Brain Res, 198, 47, 10.1016/B978-0-444-59489-1.00005-7
Tsuneki, 2008, Age-related insulin resistance in hypothalamus and peripheral tissues of orexin knockout mice, Diabetologia, 51, 657, 10.1007/s00125-008-0929-8
Yi, 2009, A major role for perifornical orexin neurons in the control of glucose metabolism in rats, Diabetes, 58, 1998, 10.2337/db09-0385
Yi, 2010, Pituitary adenylate cyclase-activating polypeptide stimulates glucose production via the hepatic sympathetic innervation in rats, Diabetes, 59, 1591, 10.2337/db09-1398
Shiuchi, 2009, Hypothalamic orexin stimulates feeding-associated glucose utilization in skeletal muscle via sympathetic nervous system, Cell Metab, 10, 466, 10.1016/j.cmet.2009.09.013
Honda, 1986, Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients, Sleep, 9, 254, 10.1093/sleep/9.1.254
Roberts, 1963, The syndrome of narcolepsy and diabetogenic (“functional”) hyperinsulinism. Observations on 190 patients, with emphasis upon its relationship to obesity, diabetes mellitus and cerebral dysrhythmias, J Fla Med Assoc, 50, 355
Roberts, 1964, The syndrome of narcolepsy and diabetogenic (“functional”) hyperinsulinism, with special reference to obesity, diabetes, idiopathic edema, cerebral dysrhythmias and multiple sclerosis (200 patients), J Am Geriatr Soc, 12, 926, 10.1111/j.1532-5415.1964.tb00642.x
Poli, 2009, Body mass index-independent metabolic alterations in narcolepsy with cataplexy, Sleep, 32, 1491, 10.1093/sleep/32.11.1491
Engel, 2011, Investigation of insulin resistance in narcoleptic patients: dependent or independent of body mass index?, Neuropsychiatr Dis Treat, 7, 351, 10.2147/NDT.S18455
Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883
Cowie, 2010, Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006, Diabetes Care, 33, 562, 10.2337/dc09-1524
Kahn, 2001, Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes, J Clin Endocrinol Metab, 86, 4047
DeFronzo, 1979, Glucose clamp technique: a method for quantifying insulin secretion and resistance, Am J Physiol, 237, E214
The Xyrem International Study Group, 2005, A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy, J Clin Sleep Med, 1, 391, 10.5664/jcsm.26368
Carter, 2009, Behavioral analyses of GHB: receptor mechanisms, Pharmacol Ther, 121, 100, 10.1016/j.pharmthera.2008.10.003
Pijl, 2003, Reduced dopaminergic tone in hypothalamic neural circuits: expression of a “thrifty” genotype underlying the metabolic syndrome?, Eur J Pharmacol, 480, 125, 10.1016/j.ejphar.2003.08.100
Husain, 2009, Weight loss in narcolepsy patients treated with sodium oxybate, Sleep Med, 10, 661, 10.1016/j.sleep.2008.05.012
American Academy of Sleep Medicine, 2005, American Sleep Association, International classification of sleep disorders. diagnostic and coding manual, 2nd ed
Andersson, 1988, Measuring obesity- classification and description of anthropometric data report on a WHO consultation on epidemiology of obesity, 125, 1
Liu, 1992, Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia, Diabetologia, 35, 287, 10.1007/BF00400932
Jazet, 2005, Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin, Metabolism, 54, 705, 10.1016/j.metabol.2004.12.015
Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499
Steele, 1959, Influences of glucose loading and of injected insulin on hepatic glucose output, Ann N Y Acad Sci, 82, 420, 10.1111/j.1749-6632.1959.tb44923.x
Kok, 2003, Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity, Obes Res, 11, 1147, 10.1038/oby.2003.156
Tsuneki, 2012, Role of orexin in the central regulation of glucose and energy homeostasis, Endocr J, 59, 365, 10.1507/endocrj.EJ12-0030
Matsuda, 1999, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp, Diabetes Care, 22, 1462, 10.2337/diacare.22.9.1462
Khoza, 2012, Use of antidepressant agents and the risk of type 2 diabetes, Eur J Clin Pharmacol, 68, 1295, 10.1007/s00228-011-1168-3
Venner, 2011, Orexin neurons as conditional glucosensors: paradoxical regulation of sugar sensing by intracellular fuels, J Physiol, 589, 5701, 10.1113/jphysiol.2011.217000